Juan José Zarbá

ORCID: 0000-0003-1013-3993

2

h-index

2

Publications

4,942

Citations

Publications

2 shown

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness , Kevin J. Harrington , Richard Greil +97 more

2019 The Lancet 2928 citations

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares , Mikhail Dvorkin , Yuanbin Chen +97 more

2019 The Lancet 2014 citations

Frequent Co-Authors

Barbara Burtness

Yale Cancer Center

Kevin J. Harrington

Institute of Cancer Research

Richard Greil

Paracelsus Medical University

Denis Soulières

Centre Hospitalier de l’Université de Montréal

Makoto Tahara

National Cancer Center Hospital East

Gilberto de Castro

Instituto do Câncer do Estado de São Paulo

Researcher Info

h-index: 2
Publications: 2
Citations: 4,942

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1013-3993

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.